Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway

被引:72
作者
Battcock, SA [1 ]
Collier, TW [1 ]
Zu, D [1 ]
Hirasawa, K [1 ]
机构
[1] Mem Univ Newfoundland, Fac Med, Div Basic Med Sci, St John, NF A1B 3V6, Canada
关键词
D O I
10.1128/JVI.80.9.4422-4430.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Interferon (IFN) is one of the molecules released by virus-infected cells, resulting in the establishment of an antiviral state within infected and neighboring cells. IFN-induced antiviral response may be subject to modulation by the cellular signaling environment of host cells which impact the effectiveness of viral replication. Here, we show that cells with an activated Ras/Raf/MEK signaling cascade allow propagation of viruses in the presence of IFN. Ras-transformed (RasV12) and vector control NIH 3T3 cells were infected with vesicular stomatitis virus (VSV) or an IFN-sensitive vaccinia virus (deIE3L) in the presence of alpha interferon. While IFN protected vector control cells from infection by both viruses, RasV12 cells were susceptible to viral infection regardless of the presence of IFN. IFN sensitivity was restored in RasV12 cells upon RNA interference (RNAi) knockdown of Ras. We further investigated which elements downstream of Ras are responsible for counteracting IFN-induced antiviral responses. A Ras effector domain mutant that can only stimulate the Raf kinase family of effectors was able to suppress the IFN response and allow VSV replication. IFN-induced antiviral mechanisms were also restored in RasV12 cells by treatment with a MEK inhibitor (IJ0126 or PD98059). Moreover, by using RNAi to MEK1 and MEK2, we determined that MEK2, rather than MEK1, is responsible for suppression of the IFN response. In conclusion, our results suggest that activation of the Ras/Raf/MEK pathway downregulates IFN-induced antiviral response.
引用
收藏
页码:4422 / 4430
页数:9
相关论文
共 67 条
[31]   Treatment of chronic myelogenous leukemia: Current status and investigational options [J].
Kantarjian, HM ;
OBrien, S ;
Anderlini, P ;
Talpaz, M .
BLOOD, 1996, 87 (08) :3069-3081
[32]   THE 2-5A SYSTEM - A PERSONAL VIEW [J].
KERR, IM .
JOURNAL OF INTERFERON RESEARCH, 1987, 7 (05) :505-510
[33]   Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression [J].
Klampfer, L ;
Huang, J ;
Corner, G ;
Mariadason, J ;
Arango, D ;
Sasazuki, T ;
Shirasawa, S ;
Augenlicht, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) :46278-46287
[34]   Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions [J].
Kolch, W .
BIOCHEMICAL JOURNAL, 2000, 351 :289-305
[35]   ERK-1/2 activity is required for efficient RSV infection [J].
Kong, XY ;
San Juan, H ;
Behera, A ;
Peeples, ME ;
Wu, J ;
Lockey, RF ;
Mohapatra, SS .
FEBS LETTERS, 2004, 559 (1-3) :33-38
[36]  
Landolfo S, 2000, Hematol J, V1, P7, DOI 10.1038/sj.thj.6200004
[37]   The virus battles:: IFN induction of the antiviral state and mechanisms of viral evasion [J].
Levy, DE ;
García-Sastre, A .
CYTOKINE & GROWTH FACTOR REVIEWS, 2001, 12 (2-3) :143-156
[38]   Signal transduction through MAP kinase cascades [J].
Lewis, TS ;
Shapiro, PS ;
Ahn, NG .
ADVANCES IN CANCER RESEARCH, VOL 74, 1998, 74 :49-139
[39]   Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway [J].
Luo, HL ;
Yanagawa, B ;
Zhang, JC ;
Luo, ZS ;
Zhang, M ;
Esfandiarei, M ;
Carthy, C ;
Wilson, JE ;
Yang, DC ;
McManus, BM .
JOURNAL OF VIROLOGY, 2002, 76 (07) :3365-3373
[40]   Interferon regulatory factors:: the next generation [J].
Mamane, Y ;
Heylbroeck, C ;
Génin, P ;
Algarté, M ;
Servant, MJ ;
LePage, C ;
DeLuca, C ;
Kwon, H ;
Lin, RT ;
Hiscott, J .
GENE, 1999, 237 (01) :1-14